Harbor Capital Advisors, Inc. Entrada Therapeutics, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding TRDA
# of Institutions
75Shares Held
25.7MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$75.7 Million0.87% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$68.9 Million25.58% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$68.6 Million22.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.75MShares$42.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.49MShares$23.1 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $488M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...